123 related articles for article (PubMed ID: 15223899)
1. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
Transplantation; 2004 Jun; 77(12):1826-33. PubMed ID: 15223899
[TBL] [Abstract][Full Text] [Related]
2. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
Transplantation; 2005 Jun; 79(11):1553-60. PubMed ID: 15940045
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
Kahan BD; Karlix JL; Ferguson RM; Leichtman AB; Mulgaonkar S; Gonwa TA; Skerjanec A; Schmouder RL; Chodoff L
Transplantation; 2003 Oct; 76(7):1079-84. PubMed ID: 14557756
[TBL] [Abstract][Full Text] [Related]
4. FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study.
Tedesco-Silva H; Lorber MI; Foster CE; Sollinger HW; Mendez R; Carvalho DB; Shapiro R; Rajagopalan PR; Mayer H; Slade J; Kahan BD;
Clin Transplant; 2009; 23(5):589-99. PubMed ID: 19719728
[TBL] [Abstract][Full Text] [Related]
5. FTY720 immunomodulation: optimism for improved transplant regimens.
Ferguson R
Transplant Proc; 2004 Mar; 36(2 Suppl):549S-553S. PubMed ID: 15041404
[TBL] [Abstract][Full Text] [Related]
6. FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.
Tedesco-Silva H; Szakaly P; Shoker A; Sommerer C; Yoshimura N; Schena FP; Cremer M; Hmissi A; Mayer H; Lang P;
Transplantation; 2007 Oct; 84(7):885-92. PubMed ID: 17984842
[TBL] [Abstract][Full Text] [Related]
7. The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients.
Westhoff TH; Schmidt S; Glander P; Liefeld L; Martini S; Offermann G; Neumayer HH; Zidek W; van der Giet M; Budde K
Nephrol Dial Transplant; 2007 Aug; 22(8):2354-8. PubMed ID: 17526535
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
Tedesco-Silva H; Pescovitz MD; Cibrik D; Rees MA; Mulgaonkar S; Kahan BD; Gugliuzza KK; Rajagopalan PR; Esmeraldo Rde M; Lord H; Salvadori M; Slade JM;
Transplantation; 2006 Dec; 82(12):1689-97. PubMed ID: 17198261
[TBL] [Abstract][Full Text] [Related]
9. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
[TBL] [Abstract][Full Text] [Related]
10. FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction.
Kovarik JM; Schmouder RL; Barilla D; Büche M; Rouilly M; Berthier S; Wang Y; Van Saders C; Mayer T; Gottlieb AB
Ann Pharmacother; 2004; 38(7-8):1153-8. PubMed ID: 15138297
[TBL] [Abstract][Full Text] [Related]
11. FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship.
Skerjanec A; Tedesco H; Neumayer HH; Cole E; Budde K; Hsu CH; Schmouder R
J Clin Pharmacol; 2005 Nov; 45(11):1268-78. PubMed ID: 16239360
[TBL] [Abstract][Full Text] [Related]
12. FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study.
Hoitsma AJ; Woodle ES; Abramowicz D; Proot P; Vanrenterghem Y;
Nephrol Dial Transplant; 2011 Nov; 26(11):3802-5. PubMed ID: 21911597
[TBL] [Abstract][Full Text] [Related]
13. FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia.
Salvadori M; Budde K; Charpentier B; Klempnauer J; Nashan B; Pallardo LM; Eris J; Schena FP; Eisenberger U; Rostaing L; Hmissi A; Aradhye S;
Am J Transplant; 2006 Dec; 6(12):2912-21. PubMed ID: 17061999
[TBL] [Abstract][Full Text] [Related]
14. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
Sommerer C; Morath C; Giese T; Meuer S; Zeier M
Transplant Proc; 2008 Jun; 40(5):1416-8. PubMed ID: 18589120
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
[TBL] [Abstract][Full Text] [Related]
16. FTY720: early clinical experience.
Dragun D; Fritsche L; Boehler T; Peters H; Budde K; Neumayer HH
Transplant Proc; 2004 Mar; 36(2 Suppl):544S-548S. PubMed ID: 15041403
[TBL] [Abstract][Full Text] [Related]
17. A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments.
Suzuki T; Jin MB; Shimamura T; Yamashita K; Taniguchi M; Nomura M; Yokota R; Fukai M; Magata S; Horiuchi H; Fujita M; Nagashima K; Furukawa H; Todo S
Transpl Int; 2004 Nov; 17(10):574-84. PubMed ID: 15592714
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients.
Nart A; Sipahi S; Aykas A; Uslu A; Hoşcoşkun C; Toz H
Transplant Proc; 2008; 40(1):189-92. PubMed ID: 18261583
[TBL] [Abstract][Full Text] [Related]
19. FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study.
Mulgaonkar S; Tedesco H; Oppenheimer F; Walker R; Kunzendorf U; Russ G; Knoflach A; Patel Y; Ferguson R;
Am J Transplant; 2006 Aug; 6(8):1848-57. PubMed ID: 16771816
[TBL] [Abstract][Full Text] [Related]
20. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
